4.7.2 Opioid analgesics
When used opioid patches should be prescribed by brand
Additional NICE Guidance:
NICE CG140: Palliative care for adults - strong opioids for pain relief
NICE NG61: End of life care for infants, children and young people with life-limiting conditions: planning and management
NICE NG59: Low back pain and sciatica in over 16s: assessment and management
Other useful links and documents:
Guidance for clinicians:
Useful Links:
Live Well with Pain provides many practical resources, including videos, to support self-empowerment to manage pain through non-pharmacological methods.
Opioids Aware the Faculty of Pain Medicine provides a wealth of information for people living with persistent pain and healthcare professionals on opioid medicines.
RCGP top 10 tips: dependence forming medicines - The Royal College of General Practitioners has produced guidance for general practice teams, which succinctly outlines the key issues to consider when prescribing DFMs.
Resources to support people living with persistent pain:
Buprenorphine patch dose reduction patient information
Fentanyl patch dose reduction patient information
Morphine dose reduction patient information
Opioids in persistent pain patient information leaflet
Oxycodone dose reduction patient information
Useful links:
My Live Well with Pain provides many practical resources to support people in the management of pain through non-pharmacological methods.
Pack |
---|
30 tablet |
Pack |
---|
30 tablet |
Pack |
---|
30 tablet |
Pack |
---|
500 ml |
Controlled Drug 2
Pack |
---|
10 ampoule |
Pack |
---|
5 ampoule |
Pack |
---|
5 ampoule |
Pack |
---|
5 ampoule |
Pack |
---|
5 ampoule |
Pack |
---|
5 ampoule |
For use in the Emergency Department only
Pack |
---|
68 dose |
For use in the Emergency Department only
Pack |
---|
68 dose |
Controlled Drug except for oral solution 10mg in 5ml
Prescribe modified-release preparations by brand
Zomorph capsules can be opened and the contents sprinkled on soft food or dispersed in water
Pack |
---|
56 tablet |
Pack |
---|
56 tablet |
Pack |
---|
56 tablet |
Pack |
---|
60 capsule (6 x 10 capsules) |
Pack |
---|
60 capsule (6 x 10 capsules) |
Pack |
---|
60 capsule (6 x 10 capsules) |
Pack |
---|
60 capsule (6 x 10 capsules) |
Pack |
---|
60 capsule (6 x 10 capsules) |
Contains alchohol
Pack |
---|
100 ml |
Pack |
---|
5 vial |
Pack |
---|
5 ampoule |
To be used for dose tapering regimes
Pack |
---|
60 tablet (2 x 30 tablets) |
Prescribe modified-release preparations by brand
Pack |
---|
56 capsule |
Pack |
---|
56 capsule |
Pack |
---|
56 capsule |
Pack |
---|
28 tablet (2 x 14 tablets) |
Pack |
---|
56 tablet (4 x 14 tablets) |
Pack |
---|
56 tablet (4 x 14 tablets) |
Pack |
---|
56 tablet (4 x 14 tablets) |
Pack |
---|
56 tablet (4 x 14 tablets) |
Pack |
---|
120 ml |
Pack |
---|
5 ampoule |
Use with caution with patients with a history of epilepsy
Psychiatric reactions have been reportedÂ
Pack |
---|
100 capsule |
Pack |
---|
60 capsule |
Pack |
---|
60 tablet |
Pack |
---|
60 capsule |
Pack |
---|
60 tablet |
Pack |
---|
60 capsule |
Pack |
---|
60 tablet |
Pack |
---|
60 capsule |
- First Line Drugs
- Second Line Drugs
- Specialist Initiated Drugs
- Specialist Only Drugs
- Mixed Status